last data update: 2011/10/21, 01:06

Website loading time

during the test: 1.08 s

cable connection (average): 1.38 s

DSL connection (average): 1.69 s

modem (average): 17.73 s

HTTP headers

Information about DNS servers

hivandhepatitis.comSOAfeed19.nameservers.nethostmaster.rapidsite.net20110712207200 3600 604800 86400 IN 43200
hivandhepatitis.comMX50mail-fwd.mx.g19.rapidsite.netIN1200
hivandhepatitis.comA173.230.152.32IN1200
hivandhepatitis.comNSns19b.nameservers.netIN1200
hivandhepatitis.comNSns19a.nameservers.netIN1200

Received from the first DNS server

Request to the server "hivandhepatitis.com"
You used the following DNS server:
DNS Name: ns19b.nameservers.net
DNS Server Address: 198.170.241.2#53
DNS server aliases:

HEADER opcode: REQUEST, status: NOERROR, id: 36494
flag: qr aa rd REQUEST: 1, ANSWER: 5, AUTHORITY: 2, ADDITIONAL: 5

REQUEST SECTION:
hivandhepatitis.com. IN ANY

ANSWER SECTION:
hivandhepatitis.com. 1200 IN A 173.230.152.32
hivandhepatitis.com. 1200 IN MX 50 mail-fwd.mx.g19.rapidsite.net.
hivandhepatitis.com. 1200 IN NS ns19a.nameservers.net.
hivandhepatitis.com. 1200 IN NS ns19b.nameservers.net.
hivandhepatitis.com. 86400 IN SOA feed19.nameservers.net. hostmaster.rapidsite.net. 2011071220 7200 3600 604800 86400

AUTHORITY SECTION:
hivandhepatitis.com. 1200 IN NS ns19a.nameservers.net.
hivandhepatitis.com. 1200 IN NS ns19b.nameservers.net.

SECTION NOTES:
mail-fwd.mx.g19.rapidsite.net. 181 IN A 199.239.254.18
ns19a.nameservers.net. 86400 IN A 161.58.134.98
ns19a.nameservers.net. 86400 IN A 161.58.75.72
ns19b.nameservers.net. 86400 IN A 161.58.134.114
ns19b.nameservers.net. 86400 IN A 198.170.241.2

Received 312 bytes from address 198.170.241.2#53 in 20 ms

Received from the second DNS server

Request to the server "hivandhepatitis.com"
You used the following DNS server:
DNS Name: ns19a.nameservers.net
DNS Server Address: 161.58.75.72#53
DNS server aliases:

HEADER opcode: REQUEST, status: NOERROR, id: 41364
flag: qr aa rd REQUEST: 1, ANSWER: 5, AUTHORITY: 2, ADDITIONAL: 5

REQUEST SECTION:
hivandhepatitis.com. IN ANY

ANSWER SECTION:
hivandhepatitis.com. 1200 IN A 173.230.152.32
hivandhepatitis.com. 1200 IN MX 50 mail-fwd.mx.g19.rapidsite.net.
hivandhepatitis.com. 1200 IN NS ns19a.nameservers.net.
hivandhepatitis.com. 1200 IN NS ns19b.nameservers.net.
hivandhepatitis.com. 86400 IN SOA feed19.nameservers.net. hostmaster.rapidsite.net. 2011071220 7200 3600 604800 86400

AUTHORITY SECTION:
hivandhepatitis.com. 1200 IN NS ns19a.nameservers.net.
hivandhepatitis.com. 1200 IN NS ns19b.nameservers.net.

SECTION NOTES:
mail-fwd.mx.g19.rapidsite.net. 102 IN A 199.239.254.18
ns19a.nameservers.net. 86400 IN A 161.58.134.98
ns19a.nameservers.net. 86400 IN A 161.58.75.72
ns19b.nameservers.net. 86400 IN A 161.58.134.114
ns19b.nameservers.net. 86400 IN A 198.170.241.2

Received 312 bytes from address 161.58.75.72#53 in 18 ms

Subdomains (the first 50)

Typos (misspells)

givandhepatitis.com
bivandhepatitis.com
nivandhepatitis.com
jivandhepatitis.com
uivandhepatitis.com
yivandhepatitis.com
huvandhepatitis.com
hjvandhepatitis.com
hkvandhepatitis.com
hovandhepatitis.com
h9vandhepatitis.com
h8vandhepatitis.com
hicandhepatitis.com
hibandhepatitis.com
higandhepatitis.com
hifandhepatitis.com
hivzndhepatitis.com
hivsndhepatitis.com
hivwndhepatitis.com
hivqndhepatitis.com
hivabdhepatitis.com
hivamdhepatitis.com
hivajdhepatitis.com
hivahdhepatitis.com
hivanshepatitis.com
hivanxhepatitis.com
hivanchepatitis.com
hivanfhepatitis.com
hivanrhepatitis.com
hivanehepatitis.com
hivandgepatitis.com
hivandbepatitis.com
hivandnepatitis.com
hivandjepatitis.com
hivanduepatitis.com
hivandyepatitis.com
hivandhwpatitis.com
hivandhspatitis.com
hivandhdpatitis.com
hivandhrpatitis.com
hivandh4patitis.com
hivandh3patitis.com
hivandheoatitis.com
hivandhelatitis.com
hivandhe-atitis.com
hivandhe0atitis.com
hivandhepztitis.com
hivandhepstitis.com
hivandhepwtitis.com
hivandhepqtitis.com
hivandheparitis.com
hivandhepafitis.com
hivandhepagitis.com
hivandhepayitis.com
hivandhepa6itis.com
hivandhepa5itis.com
hivandhepatutis.com
hivandhepatjtis.com
hivandhepatktis.com
hivandhepatotis.com
hivandhepat9tis.com
hivandhepat8tis.com
hivandhepatiris.com
hivandhepatifis.com
hivandhepatigis.com
hivandhepatiyis.com
hivandhepati6is.com
hivandhepati5is.com
hivandhepatitus.com
hivandhepatitjs.com
hivandhepatitks.com
hivandhepatitos.com
hivandhepatit9s.com
hivandhepatit8s.com
hivandhepatitia.com
hivandhepatitiz.com
hivandhepatitix.com
hivandhepatitid.com
hivandhepatitie.com
hivandhepatitiw.com
ivandhepatitis.com
hvandhepatitis.com
hiandhepatitis.com
hivndhepatitis.com
hivadhepatitis.com
hivanhepatitis.com
hivandepatitis.com
hivandhpatitis.com
hivandheatitis.com
hivandheptitis.com
hivandhepaitis.com
hivandhepattis.com
hivandhepatiis.com
hivandhepatits.com
hivandhepatiti.com
ihvandhepatitis.com
hviandhepatitis.com
hiavndhepatitis.com
hivnadhepatitis.com
hivadnhepatitis.com
hivanhdepatitis.com
hivandehpatitis.com
hivandhpeatitis.com
hivandheaptitis.com
hivandheptaitis.com
hivandhepaittis.com
hivandhepattiis.com
hivandhepatiits.com
hivandhepatitsi.com
hhivandhepatitis.com
hiivandhepatitis.com
hivvandhepatitis.com
hivaandhepatitis.com
hivanndhepatitis.com
hivanddhepatitis.com
hivandhhepatitis.com
hivandheepatitis.com
hivandheppatitis.com
hivandhepaatitis.com
hivandhepattitis.com
hivandhepatiitis.com
hivandhepatittis.com
hivandhepatitiis.com
hivandhepatitiss.com

Location

IP: 173.230.152.32

continent: NA, country: United States (USA), city: Absecon

Website value

rank in the traffic statistics:

There is not enough data to estimate website value.

Basic information

website build using CSS

code weight: 116.57 KB

text per all code ratio: 22 %

title: HOME | hivandhepatitis.com

description: Up-to-date information about approved and experimental therapies for HIV/AIDS, Hepatitis, and related conditions.

keywords:

encoding: utf-8

language: en-GB

Website code analysis

one word phrases repeated minimum three times

PhraseQuantity
HIV33
of31
Hepatitis28
for23
HCV22
the20
and20
HBV18
to18
in17
Treatment13
U.S.11
EACS:10
MORE:10
Testing9
with8
Diagnosis8
Disease8
on8
Prevention8
People7
Vaccine7
20116
Show6
HIV/AIDS6
Items6
October6
Liver6
New6
Effects6
The6
Patients5
at5
Side5
Guidelines5
Progression5
have4
week4
Advocacy4
Populations4
May4
that4
Helps4
AIDS4
therapy4
Conditions4
Health4
hepatitis4
Department4
READ4
Human4
MORE...4
Services4
Therapy4
Policy4
Entecavir4
AASLD4
HIVandHepatitis.com4
FDA4
Tuesday,4
184
Prevalence3
Test3
new3
virus3
Updated3
Study3
Image3
Hide3
Link3
Response3
(Baraclude)3
Other3
researchers3
Predicts3
as3
ICAAC:3
Intro3
guidelines3
Effective3
during3
European3
Setting3
last3
all3
Check3
Risk3
Coinfected3
Basic3
Science3
from3
Epidemiology3
Resources3

two word phrases repeated minimum three times

PhraseQuantity
Testing Diagnosis7
Side Effects5
the U.S.4
Disease Progression4
Hepatitis Treatment4
18 October4
October 20114
U.S. Department4
Department of4
Policy Advocacy4
READ MORE...4
for Hepatitis4
for the4
Human Services4
Health and4
and Human4
Tuesday, 184
of Health4
Items Link3
Link Items3
Intro Items3
U.S. and3
Check all3
HIV Prevention3
last week3
Image Show3
Show Hide3
Effects HCV3
Show Image3
Items Show3
Setting Check3
European AIDS3
People with3
HIV Treatment3
Basic Science3

three word phrases repeated minimum three times

PhraseQuantity
of Health and4
Health and Human4
and Human Services4
Department of Health4
U.S. Department of4
Tuesday, 18 October4
18 October 20114
Link Items Show3
Items Link Items3
Setting Check all3
Show Image Show3
Intro Items Link3
Items Show Image3
Image Show Hide3

B tags

51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)

6th International AIDS Society Conference on HIV Pathogenesis, Treatment & Prevention (IAS 2011)

46th Annual Meeting of the European Association for the Study of the Liver (EASL 2011)

18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)

61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2010)

50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2010)

XVIII International AIDS Conference (AIDS 2010)

U tags

I tags

images

file namealternative text
feed-image
HIVandHepatitis.com
Guidelines Galore: U.S. and EACS Update HIV Recommendations, AASLD Revision Adds New HCV Drugs
EACS: Raltegravir Demonstrates Continued Efficacy at 4 Years
Gambling for a Cure for HIV
Undercounted Populations Raise Estimate of True U.S. Hepatitis C Prevalence
Loading
AASLD Hepatitis C Treatment Guidelines Updated to Include Boceprevir and Telaprevir
EACS: Switching from Efavirenz to Rilpivirine Single Tablet Regimen Is Safe and Effective
EACS: IL28B Gene Variant that Helps Hepatitis C Treatment May Hinder HIV Treatment
EACS: Incidence of Non-AIDS Malignancies Stabilizes in D:A:D Study, but Prognosis Improves
EACS: Antiretroviral Therapy Reduces Liver Fibrosis Progression in HIV/HCV Coinfected People
EACS: Dolutegravir Twice-Daily is More Effective for Treatment-Experienced HIV Patients
EACS: Neurocognitive Impairment in People with HIV
Positive Pulse: Expert Commentaries From IAS 2011
Together We Can: Improving HIV Testing, Treatment, and Adherence in Black and Hispanic Communities dinner meeting series
TREATING HIV EARLY: 10 CLINICAL CONSIDERATIONS
alt

headers

H1

H2

H3

H4

H5

H6

internal links

addressanchor text
hivandhepatitis.com
RSS
Contact Us
Home
About us
Overview
Our Team
The Fine Print
Get in touch
Contact Us
Content
Conferences
Library of CME Programs
HIV/AIDS
HIV/AIDS Topics
HIV Prevention
HIV Disease Progression
HIV Populations
HIV Treatment
HIV Testing & Diagnosis
HIV-Related Conditions
Hepatitis B
Hepatitis B Topics
HBV Treatment
HBV Disease Progression
HBV Populations
HBV Prevention
HBV Testing & Diagnosis
Hepatitis C
Hepatitis C Topics
HCV Treatment
HCV Prevention
HCV Disease Progression
HCV Populations
Side Effects - HCV
Coinfection
HIV & Hepatitis Coinfection
HIV/HCV Coinfection
HIV/HBV Coinfection
Other Infections
Other Infections
Human Papillomavirus (HPV)
Other STDs
Tuberculosis
Influenza
XMRV & Other Retroviruses
Skip to content
READ MORE...
READ MORE...
READ MORE...
READ MORE...
Updated DHHS Antiretroviral Therapy Guidelines Reclassify Some First-Line Drugs
California Governor Signs Syringe Purchase and Needle Exchange Bills
CDC Testing Push Increased HIV Diagnosis
U.S. Department of Health and Human Services Allocates Nearly $2 Billion for HIV/AIDS Care
Entecavir (Baraclude) Less Effective for Patients with Multidrug-Resistant Hepatitis B
ICAAC: Double Dose of Hepislav Works as Well as 3 Doses of Standard HBV Vaccine
Interpreting Hepatitis B Tests
Occult Hepatitis B Infection May Be the Cause of Unexplained Liver Cancer
EACS: People on Methadone Maintenance Can Be Successfully Treated for Hepatitis C
Discovery May Aid Development of Hepatitis C Vaccine
FDA OKs New Abbott HCV Test
Anemia during Hepatitis C Treatment Predicts Sustained Response to Pegylated Interferon/ribavirin
Hepatitis B and C Coinfection among HIV Positive People in the U.S.
ICAAC: HCV Drug Telaprevir Shows No Problematic Interactions with Raltegravir
Risk Factors for Tuberculosis among HIV Positive People in the US and Canada
Sexual Partners Should Get Expedited Treatment for Chlamydia and Gonorrhea
Rising Rate of Mouth and Throat Cancers Caused by HPV
Ribavirin May Be Effective against Acute Hepatitis E
Positive Pulse: Expert Commentaries From IAS 2011
Positive Pulse: Expert Commentaries From IAS 2011
Positive Pulse: Expert Commentaries From IAS 2011
Together We Can: Improving HIV Testing, Treatment, and Adherence in Black and Hispanic Communities dinner meeting series
13th European AIDS Conference
51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
6th International AIDS Society Conference on HIV Pathogenesis, Treatment & Prevention (IAS 2011)
alt
46th Annual Meeting of the European Association for the Study of the Liver (EASL 2011)
alt
18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2010)
alt
50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2010)
XVIII International AIDS Conference (AIDS 2010)
hivandhepatitis.com
Home
About
Contact Us

external links

addressanchor text
Youtube
Twitter
HIVandHepatitis.com
EACS
HIV
AASLD
HepC
http://t.co/3sx0ihti
HIVandHepatitis.com
AASLD
HepC
http://t.co/7pEbgzZp
HIVandHepatitis.com
EACS
HIV
http://t.co/gFAzazoB
HIVandHepatitis.com
EACS
HepC
HIV
http://t.co/pq8lcooa
Facebook
RSS Feed
Find Us on Facebook
Library of CME Programs
TREATING HIV EARLY: 10 CLINICAL CONSIDERATIONS
JoomlArt.com
Joomla!
GNU General Public License.